MIAO, XIAONIU,HU, HUAJING,LIU, JUNJIAN,CHEN, BINGLIANG,LI, LI
申请号：
CA3076447
公开号：
CA3076447A1
申请日:
2018.12.27
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The invention provides an antibody and fragment thereof specifically binding to PD-L1, a composition containing the antibody or fragment thereof, a nucleic acid encoding the antibody or fragment thereof, a corresponding host cell and the uses thereof. Moreover, the invention also provides a type of therapy that uses a combination of the antibody and fragment thereof with other therapies.
